Literature DB >> 11514031

Structure-activity relationships of neuropeptide FF: role of C-terminal regions.

H Mazarguil1, C Gouardères, J A Tafani, D Marcus, M Kotani, C Mollereau, M Roumy, J M Zajac.   

Abstract

A structure-activity study was carried out to determine the importance of the C-terminal amino acids of the octapeptide Neuropeptide FF (NPFF) in binding and agonistic activity. Affinities of NPFF analogues were tested toward NPFF receptors of the rat spinal cord and the human NPFF2 receptors transfected in CHO cells. The activities of these analogues were evaluated by their ability to both inhibit adenylate cyclase in NPFF2 receptor transfected CHO cells and to reverse the effect of nociceptin on acutely dissociated rat dorsal raphe neurons. The substitutions of Phenylalanine8 by a tyrosine, phenylglycine or homophenylalanine were deleterious for high affinity. Similarly, the replacement of Arginine7 by a lysine or D. Arginine induces a loss in affinity. The pharmacological characterization showed that the presence of the amidated Phe8 and Arg7 residues are also extremely critical for activation of anti-opioid effects on dorsal raphe neurons. The sequence of the C-terminal dipeptide seems also to be responsible for the high affinity and the activity on human NPFF2 receptors. The results support the view that a code messaging the molecular interaction toward NPFF-receptors is expressed in the C-terminal region of these peptides but the N-terminal segment is important to gain very high affinity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514031     DOI: 10.1016/s0196-9781(01)00468-5

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

Review 1.  The Arg-Phe-amide peptide 26RFa/glutamine RF-amide peptide and its receptor: IUPHAR Review 24.

Authors:  Jérôme Leprince; Didier Bagnol; Ronan Bureau; Shoji Fukusumi; Riccarda Granata; Shuji Hinuma; Dan Larhammar; Stefany Primeaux; Jana Sopkova-de Oliveiras Santos; Kazuyoshi Tsutsui; Kazuyoshi Ukena; Hubert Vaudry
Journal:  Br J Pharmacol       Date:  2017-09-08       Impact factor: 8.739

2.  Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors.

Authors:  V Blair Journigan; Christophe Mésangeau; Neha Vyas; Shainnel O Eans; Stephen J Cutler; Jay P McLaughlin; Catherine Mollereau; Christopher R McCurdy
Journal:  J Med Chem       Date:  2014-10-21       Impact factor: 7.446

3.  Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity.

Authors:  Nicolas Chartrel; Cynthia Dujardin; Youssef Anouar; Jérôme Leprince; Annick Decker; Stefan Clerens; Jean-Claude Do-Régo; Frans Vandesande; Catherine Llorens-Cortes; Jean Costentin; Jean-Claude Beauvillain; Hubert Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

4.  Evidence for the Direct Effect of the NPFF Peptide on the Expression of Feeding-Related Factors in Spotted Sea Bass (Lateolabrax maculatus).

Authors:  Qing Li; Haishen Wen; Yun Li; Zhanxiong Zhang; Yangyang Zhou; Xin Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.